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Introduction
Gram-negative bacteria assemble a highly conserved outer membrane (OM) barrier.
Glycerophospholipids comprise the periplasmic monolayer of the asymmetric lipid bilayer, while the surface-exposed monolayer is enriched with lipopolysaccharide (LPS). The LPS glycolipid is organized into three domains; an O-antigen carbohydrate repeat, core oligosaccharide, and the membrane anchor, lipid A (1) . The lipid A domain is initially synthesized as a β-1',6-linked glucosamine disaccharide that is both phosphorylated and fatty acylated. Lipid A is the bioactive portion of LPS and robustly activates the human Toll-like receptor 4 (TLR-4) and myeloid differentiation factor 2 (MD-2) immune complex to induce immune reactivity (1) (2) (3) (4) . Gram-negative pathogens encode highly conserved regulatory mechanisms that modify lipid A to prevent TLR-4/MD-2 recognition and to fortify the OM against immune effectors and antimicrobials, which promotes survival in the host (5) .
Lipid A modification enzymes are transcriptionally regulated by two-component systems (TCS) (6, 7) . The PmrAB and PhoPQ TCSs are well-studied phosphorelay signaling systems that regulate lipid A modifications in response to specific environmental signals (8) (9) (10) . PmrAB and PhoPQ are highly conserved among pathogenic Enterobacteriaceae (11) .
PmrAB responds to high Fe 3+ concentrations, cationic antimicrobial peptides (CAMPs), and slightly acidic pH to directly activate eptA (also known as pmrC) and arn operon expression (12) (13) (14) , which encode phosphoethanolamine (pEtN) and 4-amino-4-deoxy-L-arabinose (L-Ara4N) transferases, respectively (15) (16) (17) (18) . Cationic amine addition to the lipid A domain of LPS neutralizes the surface charge to protect the cell from CAMP-mediated lysis (15, 17) .
PhoPQ is activated in response to depletion of divalent cations such as Mg 2+ and Ca 2+ and the presence of CAMPs (8, 10, 19) . PhoPQ phosphotransfer directly activates transcription of genes encoding PagL (only in Salmonella (5) ) and PagP, which add or remove acyl chains from lipid A, respectively (8, (20) (21) (22) . Additionally, it directly activates A c c e p t e d M a n u s c r i p t arn expression in Klebsiella and Yersinia spcs. (23, 24) . While the PmrAB and PhoPQ TCSs each regulate distinct subsets of genes, the independent signaling pathways also converge through the connector protein, PmrD (25-27). PmrD binds phospho-PmrA, which prevents PmrB-mediated dephosphorylation (25, (28) (29) (30) . Constitutive PmrA-dependent gene expression increases pEtN and L-Ara4N lipid A modifications.
The Enterobacter cloacae complex (ECC) is composed of thirteen closely-related Gram-negative bacterial clusters (designated C-I to C-XIII) (31). ECC are typically associated with the host microbiota. However, many clusters have been associated with hospital-acquired infections, especially in immunocompromised patients (32) . Infections manifest in a wide range of host tissues with symptoms including skin, respiratory tract, urinary tract, wound and blood infections (33). ECC have increasingly emerged in nosocomial settings and are problematic because they harbor multidrug resistance (MDR) mechanisms, which limit treatment options (32, 34-36). Alternative last-line therapeutics used to treat MDR Gram-negative infections include the CAMP, colistin (polymyxin E), which binds the lipid A portion of LPS to perturb the outer membrane and lyse the bacterial cell. Despite success as a last-line therapeutic (37, 38), many ECC clusters demonstrate heteroresistance, where a subset of the clonal population is colistin resistant (34, 39-41). We do not fully understand the underlying molecular mechanism(s) that regulate colistin heteroresistance in ECC; further characterization will advance our understanding of antimicrobial resistance and could help inform new treatment strategies.
A previous report showed that colistin heteroresistance naturally occurs within clonal ECC clusters (34). Moreover, colistin heteroresistance in E. cloacae was induced by innate immune defenses within a murine infection model, which led to treatment failure (39).
Transcriptional analysis of susceptible and resistant populations suggested that pEtN and L-

Ara4N lipid A modifications contribute to heteroresistance (39) and PhoPQ contributed to
A c c e p t e d M a n u s c r i p t regulation (34, 39), as described in other Enterobacteriaceae (11) . However, it was not established that the lipid A modifications actually occur, nor has PhoPQ-dependent, PmrABindependent regulation of colistin heteroresistance been fully described in E. cloacae or other ECC isolates.
Herein, we demonstrate that E. cloacae colistin heteroresistance involves PhoPQ Ecl , which regulates L-Ara4N modification of lipid A. The PhoP Ecl response regulator directly binds to the promoter region of arnB Ecl , which is the first gene of a seven-gene operon (arnBCADTEF Ecl ). Transcriptomics analysis supports a model of PhoPQ-dependent, PmrABindependent arn Ecl regulation. Furthermore, L-Ara4N modification of lipid A increased in response to growth in limiting Mg 2+ , which amplified colistin resistance in a PhoPQ Ecldependent manner. Lastly, sequencing of twelve ECC colistin-susceptible isolates pinpointed mutations within the PhoPQ-dependent lipid A modification pathway that promoted colistin susceptibility. This study advances our understanding of the molecular mechanisms that mediate colistin heteroresistance in ECC.
Results
Colistin heteroresistance in E. cloacae is regulated by PhoPQ Ecl , but not PmrAB Ecl .
To elucidate the underlying mechanisms that regulate colistin heteroresistance in ECC, we analyzed a collection of E. cloacae subsp. cloacae strain ATCC 13047 genetic mutants by calculating the colony forming units (CFUs) during exponential growth in the absence and presence of colistin ( Fig 1A) . While wild type and all mutant E. cloacae strains grew in standard growth media, ∆phoPQ Ecl was not viable when 10 µg/ml of colistin was added to the media. Clinical resistance to colistin is defined as >4 µg/ml (42) . The decrease in ∆phoPQ Ecl cell viability suggested that PhoPQ Ecl contributes to colistin heteroresistance. Furthermore, wild type E. cloacae grown in colistin demonstrated approximately ten-fold less CFUs at A c c e p t e d M a n u s c r i p t hour two (P <0.05), suggesting a survival defect in early logarithmic growth phase. However, the fitness defect was no longer significant at hour three. By hour four, CFUs were equivalent to growth without colistin ( Fig 1A) .
Due to reports of colistin heteroresistance in E. cloacae and other ECC strains (34, 39), we subjected wild type, ∆phoPQ Ecl , ∆phoPQ Ecl /pPhoPQ Ecl , and ∆pmrAB Ecl E. cloacae to colistin E-test strip analysis, which provides a convenient method to observe heteroresistance ( Fig S1) . Squatter colonies within the zone of inhibition indicated colistin heteroresistance in wild type, ∆phoPQ Ecl /pPhoPQ Ecl , and ∆pmrAB Ecl strains, but not ∆phoPQ Ecl . We confirmed colistin heteroresistance by population analysis profiling (PAP) ( 
Since lipid A modifications induce colistin resistance in pathogenic
Enterobacteriaceae (11) , we analyzed wild type and mutant E. cloacae lipid A for modifications. 32 P-radiolabelled lipid A was isolated and chromatographically separated based on hydrophobicity. As controls, we also analyzed lipid A from E. coli strain W3110 ( Fig 1B, lane 1) , which does not significantly modify its lipid A, and E. coli strain WD101 ( Fig 1B, lane 9) , which constitutively expresses pmrA to produce modified lipid A (15) . Thin layer chromatography (TLC) analysis indicated that wild type E. cloacae produced a mixture of lipid A consistent with modified and unmodified species ( Fig 1B, lane 2) . ∆phoPQ Ecl and the ∆arn Ecl strains did not produce modified lipid A ( Fig 1B, lanes 3 . These results confirm that PhoPQ Ecl phosphotransfer and L-Ara4N biosynthesis are essential for lipid A modification in E. cloacae. Interestingly, the pmrAB Ecl mutant assembled a modified lipid A, similar to wild type ( Fig 1B, lane 7) , and exhibited colistin heteroresistance ( Fig 1A, Table 1 , Fig S1A) , suggesting that PmrAB Ecl does not regulate colistin heteroresistance in E. cloacae.
The lipid A anchor of LPS is a pathogen associated molecular pattern (PAMP) that is bound with high affinity by the mammalian host TLR-4/MD-2 complex (44), which activates a proinflammatory response to clear the bacterial infection (45) . Structural alterations to lipid A can dramatically alter TLR-4/MD-2-dependent host immune activation (2) and a previous report nicely demonstrated that E. cloacae colistin heteroresistance was induced by innate immune effectors (39). Therefore, we examined if E. cloacae containing modified or unmodified lipid A would differentially activate TLR-4/MD-2 in a human embryonic kidney reporter cell line (HEK-blue) (2) . Wild type and phoPQ Ecl mutant strains stimulated TLR-4/MD-2-dependent activation equally ( Fig S1B) , suggesting that lipid A modifications do not significantly alter host immune recognition. Reporter activation by E. cloacae lipid A was attenuated compared to E. coli lipid A at higher cell densities, suggesting differential recognition by the human TLR-4/MD-2 complex. The Gram-positive Staphylococcus aureus, which does not produce lipid A, did not stimulate the TLR-4/MD-2 complex ( Fig S1B) .
Thus, while PhoPQ Ecl -dependent lipid A modifications contribute to CAMP resistance in E. cloacae, they do not significantly affect innate immune recognition and reactivity.
A c c e p t e d M a n u s c r i p t
Determination of E. cloacae lipid A modifications.
In order to define outer membrane modifications, we isolated lipid A from wild type E. cloacae grown in media supplemented with 10 µg/ml of colistin and from ∆phoPQ Ecl , which was grown without colistin. Purified lipid A was analyzed by direct infusion nanoESI. The Based on transcriptomics studies, a previous report suggested that E. cloacae adds pEtN and L-Ara4N to lipid A to develop colistin heteroresistance (39). However, our genetic and high resolution mass spectrometry analysis demonstrate that only L-Ara4N modifies the A c c e p t e d M a n u s c r i p t 1-and 4'-phosphates of lipid A in a PhoPQ Ecl -dependent manner (Fig 2A and B) and this amine-containing modification correlates with colistin heteroresistance ( Fig 1A and Table 1 ).
L-Ara4N lipid A modifications are dependent on PhoPQ Ecl , but not PmrAB Ecl .
To further characterize lipid A modifications in the ∆pmrAB Ecl mutant, we analyzed purified lipid A from wild type and mutant E. cloacae using MALDI-TOF mass spectrometry. Wild type produced a lipid A mixture, which included L-Ara4N modified lipids ( Fig S7A and B) .
In contrast, analysis of ∆phoPQ Ecl and ∆arn Ecl lipid A indicated that L-Ara4N modified lipids were not present. Expression of PhoPQ Ecl in trans from an IPTG-inducible promoter restored L-Ara4N modified lipid A in the phoPQ Ecl mutant. Furthermore, ∆pmrAB Ecl produced the L-Ara4N modification, similar to wild type ( Fig S7A) . The m/z of each prominent peak in our MALDI-MS analysis corresponded with the exact mass of an expected structure with only the L-Ara4N-containing structures demonstrating colistin resistance ( Fig S7B) . Here, we confirmed that L-Ara4N modification of lipid A in E. cloacae is not dependent on PmrAB Ecl .
PhoP Ecl directly binds to the arnB Ecl promoter.
The arn operon is composed of seven genes and expression is driven by a promoter upstream of arnB (16) . This genetic organization is conserved in E. cloacae as illustrated in Fig 3A. phoP expression is autoregulated in Enterobacteriaceae, where PhoP binds to the PhoP box to interact with RNA polymerase, which induces transcription (46) . The putative PhoP box in the phoP promoter region (P phoP ) is conserved in E. coli, Salmonella, and E. cloacae ( Fig   3B) . Alignment of the E. cloacae arnB promoter region (P arnB ) with E. coli, Salmonella, and E. cloacae P phoP suggested a putative PhoP box region. Importantly, E. cloacae P arnB , which contains a putative PhoP box, is highly conserved among ECC. However, this feature was not A c c e p t e d M a n u s c r i p t conserved within E. coli P arnB , suggesting regulatory mechanisms that control promoter activation are different ( Fig 3B) .
We performed electrophoretic mobility shift assays (EMSAs) using E. cloacae P arnB to determine if PhoP Ecl directly binds the promoter to activate arn Ecl transcription. Increasing concentrations of purified PhoP Ecl (Fig S8) induced a shift of the biotinylated arnB Ecl promoter fragment, which contains the putative PhoP box binding motif ( Fig 3C) .
Importantly, PhoP Ecl does not bind to E. coli P arnB , which does not encode the PhoP box motif ( Fig 3C) . Furthermore, the PhoP Ecl -arnB Ecl promoter interaction was abrogated when unlabeled E. cloacae P arnB was added in increasing amounts, as a competitive inhibitor. We also show that the interaction is specific because addition of noncompetitive DNA (poly(dI-dC)) did not reduce the PhoP Ecl and E. cloacae P arnB interaction ( Fig 3D) . Lastly, PhoP Ecl bound E. cloacae and E. coli P phoP , which both encode the nucleotide sequence specific to the PhoP box ( Fig 3E) . Together, these findings suggest that E. cloacae encodes a mechanism that enables L-Ara4N biosynthesis to respond directly to PhoPQ Ecl .
RNA-sequencing analysis of the phoPQ Ecl and pmrAB Ecl mutants.
To better understand PhoPQ Ecl and PmrAB Ecl transcriptional regulation, we isolated and sequenced total RNA from wild type and mutant E. cloacae strains. A heat map illustrates the fold change of arn Ecl , phoPQ Ecl , and pmrAB Ecl gene expression in the TCS mutants relative to wild type (Fig 4) . Expression of the arn Ecl genes were significantly down regulated in ∆phoPQ Ecl compared to wild type, suggesting that activation of the pathway is dependent on PhoPQ Ecl . In contrast, arn Ecl gene expression was not significantly altered in the ∆pmrAB Ecl mutant relative to wild type. A complete list of the significant up-and down-regulated genes (P <0.05) is included in Table S4 . Together, these analyses indicate colistin heteroresistance in wild type E. cloacae ( Fig 1A and Table 1 ) is mediated by L-Ara4N modification of lipid A, which is regulated in a PhoPQ Ecl -dependent manner under standard growth conditions. In E. coli and Salmonella, PhoPQ is activated by various signals, including low Mg 2+ and CAMPs (8, 19, 21) . Here we analyzed if PhoPQ Ecl responds to similar physiological cues to induce colistin resistance in E. cloacae. Wild type and mutant E. cloacae were grown in N minimal medium with high (10 mM) or low (10 M) Mg 2+ levels. All cultures were exposed to colistin at mid-logarithmic growth. Wild type and complemented phoPQ Ecl mutant strains grown in high Mg 2+ demonstrated some susceptibility to 5 and 10 g/ml of colistin ( Mg 2+ concentration when exposed to colistin ( Fig 5A) . These data suggest that E. cloacae PhoPQ Ecl amplifies colistin resistance in response to limiting Mg 2+ growth conditions.
PhoPQ Ecl responds to limiting Mg 2+ conditions by inducing L-Ara4N lipid A modification.
To determine if increased colistin resistance was dependent on L-Ara4N modification of lipid A, we isolated lipid A after growth in either low or high Mg 2+ . TLC analysis demonstrated that wild type and the complemented phoPQ Ecl mutant primarily produced L-Ara4N-modified (Fig 5B) and colistin resistance ( Fig 5A) throughout the population.
Inactivation of colistin heteroresistance in ECC clinical isolates.
A previous report showed that while many ECC clinical isolates were colistin heteroresistant, some were susceptible to colistin-mediated lysis. Interestingly, ECC colistin heteroresistance was cluster dependent (34). To determine the genetic basis for colistin sensitivity in ECC clusters, we examined twelve colistin susceptible clinical isolates (CI) and compared them to heteroresistant wild type ATCC 13047. We confirmed colistin susceptibility in all isolates using the BMD method to determine MICs (Table S3 ) and sequenced each genome. We obtained ~70 X 10 6 reads for each susceptible isolate and the wild type strain, which were mapped to the annotated ATCC 13047 genome (47) . The coverage region of each isolate varied between 82% to 99%, where most coverage variation occurred in plasmid DNA regions. Initial analysis of our wild type strain confirmed it did not encode mutations in the phoPQ Ecl , pmrAB Ecl , or the arn Ecl coding sequences (Table S3 ), consistent with the published annotation. In contrast, multiple mutations were found in the phoPQ Ecl and arn Ecl operons of the colistin-susceptible isolates. All of the amino acid changes in these coding regions are listed in Table S3 . Interestingly, ten of the twelve isolates encoded single nucleotide polymorphisms (SNPs) in the phoPQ Ecl promoter sequence immediately upstream of the phoP Ecl translational start codon (within 8 nucleotides), which indicated the SNPs likely disrupted the ribosome binding site ( Fig 6A) . To determine if the SNPs attenuated PhoPQdependent colistin resistance, clinical isolate-3 (CI-3) (ECC cluster III), which did not encode in CI-3 to >256 g/ml after PhoPQ Ecl signaling was restored ( Fig 6B) . Complementation suggested that SNPs in the phoPQ Ecl ribosome binding sites contributed to colistin susceptibility. SNP mutations, which abrogate translation of PhoPQ Ecl , support a model where colistin heteroresistance is dependent on PhoPQ Ecl in diverse ECC isolates.
Discussion
E. cloacae and other ECC members encode PmrAB Ecl and PhoPQ Ecl homologs. We hypothesized these TCS regulatory systems functioned together in a pathway to control L-Ara4N and pEtN modification of lipid A, based on previous transcriptomics analysis of resistant and susceptible populations (39) and because these lipid A modifications are highly conserved among Enterobacteriaceae (11) . However, our genetic and high-resolution mass spectrometry analysis of E. cloacae lipid A determined that colistin heteroresistance in E. cloacae was mediated by PhoPQ Ecl -dependent, PmrAB Ecl -independent L-Ara4N lipid A modification. Therefore, we identified a mechanism of ECC colistin heteroresistance that involves the PhoPQ system.
E. cloacae and other ECC members do not encode a PmrD homolog, which couples
PhoPQ signal transduction to regulation of PmrA-dependent genes in many Enterobacteriaceae (11 Research from other groups has outlined a complex regulatory network in E. coli and Salmonella that tightly regulates lipid A L-Ara4N and EptA modifications (15) (16) (17) (18) 25) . We hypothesize that uncoupling PmrAB Ecl regulation from L-Ara4N modification bypasses an important regulatory checkpoint, which likely promotes misregulated PhoPQ Ecl -dependent arn Ecl expression. Furthermore, colistin heteroresistance has also been associated with Klebsiella pneumoniae (48) , another Enterobacteriaceae family member that activates arn expression independently of PmrAB (23). Since selection has driven ECC and other opportunistic pathogens to maintain an altered lipid A modification signaling network, we predict that it is advantageous to maintain a CAMP resistant subpopulation in some environments. Presumably, the alternative regulatory mechanism promotes bacterial fitness in environments specific to their commensal and pathogenic niches.
Colistin heteroresistance is not well-understood at the molecular level in
Enterobacteriaceae. Our study indicates that PhoPQ Ecl signal transduction contributes to heteroresistance in ECC. However, additional studies are necessary to understand if there is a genetic determinant within the heteroresistant subpopulation that promotes resistance.
Alternatively, colistin heteroresistance could be a byproduct of promoter noise-induced bimodality, which has been linked to heteroresistance in other bacteria (49, 50) . Despite these two possibilities, our studies demonstrated that PhoPQ Ecl phosphotransfer (PhoQ H227 and PhoP D56 ) is required for colistin heteroresistance (Table 1 ), suggesting the phenotype is regulated by PhoPQ Ecl . All strains and plasmids used in this study are listed in Table S1 . Briefly, E. cloacae subsp. cloacae 13047 mutant strains were constructed as previously described using recombineering with the plasmid pKOBEG (51) . Linear PCR products were introduced in to the E. cloacae ATCC 13047/pKOBEG strain by electroporation and plated on selective media. Selected clones were transformed with pCP20 to cure the antibiotic resistance cassette.
Experimental Procedures
Bacterial Strains and Growth
To complement E. cloacae mutants, the coding sequence from phoPQ Ecl was cloned into the SalI and KpnI sites in pMMBKn (3). To generate point mutants in PhoQ H277A and PhoQ D56A , site directed mutagenesis was performed using Pfu Turbo using primers that incorporated the associated alanine-encoded nucleotide replacements. All constructs were validated using Sanger sequencing. IPTG inducible constructs were transformed into the phoPQ mutant and grown in 2.0 mM IPTG to induce expression.
Broth Microdilution assays
MICs of colistin were determined in triplicate by the broth microdilution (BMD) method.
Briefly strains were inoculated from overnight cultures when OD 600 = 0.1. Various concentrations (0 -256 g/ml) of colistin were added to each well and cultures were incubated overnight. Growth was measured by reading the OD 600 . The lowest concentration A c c e p t e d M a n u s c r i p t at which growth was inhibited was recorded as the MIC. E. coli W3110 and WD101 were used as control strains. In some cases, 'skip wells' were observed suggesting a heteroresistance phenomenon and the MIC was determined disregarding the clear wells (34).
Population Analysis
Population analysis profiling was performed by plating 1 X 10 10 CFU onto LB agar containing 1 to 64 g/ml colistin (in 2-fold increments). Plates were incubated overnight at 37 C and frequency of the subpopulation was determined by dividing by the total number of cells (43) .
Isolation of Lipid A
Isolation of lipid A for TLC analysis involved 32 P-radiolabeling of whole cells was performed as previously described with slight modifications (52) . In brief, 12.5 ml of E. cloacae was grown at 37 C to OD 600 = 1.0. Bacteria were harvested by centrifugation at 10,000 X g for 10 min. Lipid A extraction was carried out by mild-acid hydrolysis as previously described (53) . Figure S7 were collected on a MALDI-TOF/TOF (Axima Performance, Shimadzu) mass spectrometer in the negative mode. All other spectra were collected in the negative mode on a Thermo Scientific Orbitrap Fusion Lumos mass spectrometer (San Jose, CA, USA) modified with a Coherent ExciStar XS ArF excimer laser (Santa Clara, CA), as previously described (54) . HCD was performed with the normalized collision energy (NCE) of 25%. UVPD was performed with the laser emitting 193 nm photons at 5 mJ per laser pulse with 5 pulses per scan. The laser pulse repetition rate was 500 
Mass Spectrometry
MS1 spectra of lipid A in
TLR-4 Signaling Assays
HEK-Blue hTLR4, cell line was maintained according to the manufacturer specifications (Invivogen). Overnight bacterial cultures in stationary phase were serial diluted for assays as previously described (2, 3) . At least two biological replicates were each done in triplicate and one representative set was shown.
Colony Forming Unit Counts and Colistin Survival Assays
For colony forming unit counts (CFUs), E. cloacae subsp. cloacae 13047 and mutant strains were initially grown from freezer stocks on Luria-Bertani (LB) agar. Isolated colonies were resuspended and used to inoculate LB broth with 10 g/ml or without colistin at an OD 600 = 0.01. Cells were plated at designated time points on LB agar. Plates were grown overnight at 37 C and colony forming units (CFU) were counted and reported.
Colistin survival assays were performed as previously described with slight modifications (25). Briefly, wild type and mutant E. cloacae strains were grown overnight on LB agar. The following day, N minimal media pH = 7.5 containing either 10 µM MgSO 4 (low Mg 2+ ) or 10 mM MgSO 4 (high Mg 2+ ) were inoculated at OD 600 = 0.05 with bacteria from overnight cultures after cells were washed with N minimal media without Mg 2+ .
Cultures were grown until OD 600 = 0.6, when they were split and treated with 0, 5 or 10 µg/ml of colistin (Polymyxin E). Cultures were incubated for 1 h at 37 C and then colony-A c c e p t e d M a n u s c r i p t forming units were plated on LB, grown, and calculated. Percent survival was calculated by dividing the number of bacteria after treatment with colistin relative to those incubated in the absence of colistin and then multiplied by 100.
Protein Purification
To purify the PhoP Ecl protein, the coding sequence was cloned into pT7-7Kn, as previously described (55) . Briefly, the phoP Ecl coding sequence was amplified from E. cloacae cDNA with primers that added a C-terminal His 8X tag. From an overnight starter culture, 1 Liter of LB broth containing 25 µg/ml of kanamycin was inoculated at 1:50 and grown at 37 C until the OD 600 = 0.5. IPTG was added to a final concentration of 1mM, and the culture was incubated at 37 C for an additional 4 h. Bacteria were recovered by centrifugation at 10,000
x g for 10 min, and the bacteria were resuspended in lysis buffer. Bacteria were lysed using sonication and the soluble fraction was recovered by centrifugation at 10,000 x g for 30 min.
PhoP Ecl -His 8X was purified on a Ni-nitrilotriacetic acid (NTA) beads according to the manufactures instructions (Qiagen).
Electrophoretic Mobility Shift Assay
PhoP Ecl -His 8X proteins were purified as described above. EMSAs were performed based on a modified protocol (56). 250-bp DNA fragments of phoP Ecl and arnB Ecl spanning −230 to +20 relative to the translational start site were amplified from E. cloacae or E. coli cDNA using 5'-biotinylated primers. PhoP Ecl -His 8X proteins were incubated with biotinylated DNA at 25° C for 20 min. For competition experiments, unlabeled E. cloacae P arnB and poly(dI-dC) were added at 1:1, 2:1, or 5:1 ratios relative to biotin-labeled P arnB DNA. 0.1 -10 μM of PhoP Ecl -His 8X proteins were used. After electrophoresis at 4° C, protein/DNA was transferred onto a A c c e p t e d M a n u s c r i p t positively charged nylon membrane. Blots were blocked in 5% milk in TBS for 20 min and streptavidin conjugated HRP was used at a 1:300 dilution.
Nucleic Acid Extraction
Total RNA was extracted using the Direct-Zol RNA MiniPrep Kit (Zymo Research) from E. cloacae grown to a final OD 600 = 0.6. Isolated RNA was treated with DNA-free DNA removal kit (Thermo-Fisher Scientific) to eliminate genomic DNA contamination. DNasedepleted RNA was used for qRT-PCR and RNA-seq.
RNA-sequencing
RNA-sequencing was performed as previously described (57). Briefly, DNA-depleted RNA was processed for Illumina sequencing using the NEB Next Ultra Directional RNA Library Prep kit for Illumina as described by the manufacturer (NEB). Sequencing was performed 
